Find uplifting stories about heroes, innovations, and solutions
65 results for "schizophrenia"
Scientists in Israel successfully reversed schizophrenia symptoms in lab trials using targeted brain stimulation, offering hope for millions who don't respond to current treatments. The breakthrough could transform care for one-third of the world's 21 million schizophrenia patients.
Millions living with serious mental illness just got a new treatment option. The FDA approved Bysanti, offering hope for those managing bipolar 1 disorder and schizophrenia.
The FDA just approved BYSANTI, a new medication offering hope to millions of Americans living with schizophrenia and bipolar I disorder. Built on more than a decade of proven safety data, this treatment represents a faster path to innovation in mental health care.
Researchers discovered over 100 new genes linked to schizophrenia by studying African ancestry populations for the first time. The breakthrough could help doctors spot warning signs earlier and develop better treatments.
Researchers in Israel used deep-brain stimulation to dramatically reduce hallucinations in patients with treatment-resistant schizophrenia, opening a new frontier for the 30% who don't respond to medication. One patient said the voices that controlled his life finally became quiet.
The FDA just approved a new treatment option for people living with bipolar 1 disorder and schizophrenia. Bysanti offers fresh hope for millions managing these challenging mental health conditions.
A new biotech company just launched with $106 million to bring promising brain disorder treatments to Americans. Tortugas Neuroscience is testing four drugs for conditions that affect millions, including schizophrenia, tinnitus, and epilepsy.
Groundbreaking conversations are changing how families support loved ones with schizophrenia, one of the most misunderstood mental health conditions. Advocates say simple connection—sharing meals, showing up, listening without judgment—makes all the difference.
A groundbreaking opera premiering at UCLA tells the true story of renowned legal scholar Elyn Saks, who built a celebrated career while living with schizophrenia. The free performances celebrate resilience and challenge stigma around serious mental illness.
Scientists at Rutgers have identified a gene variant that may explain why mental illnesses like schizophrenia and bipolar disorder run in families. The discovery could transform how doctors treat these conditions.
UCSF researchers are using brain scans to identify who will develop schizophrenia years before psychosis starts, potentially preventing the disease entirely. Early detection could transform treatment for the 1% of people worldwide affected by this condition.
Scientists at MIT identified a gene mutation that causes the brain to get stuck on outdated beliefs and successfully reversed the effect in mice. The discovery opens promising new treatment paths for cognitive symptoms in schizophrenia patients.
A Pulitzer-nominated story reveals how a woman's schizophrenia mysteriously disappeared after cancer treatment, offering new hope for mental illness research. The deeply reported piece shows what happens when journalists build trust to tell nuanced recovery stories.
Scientists at Northwestern University discovered a biomarker that could lead to the first effective treatment for cognitive symptoms of schizophrenia, potentially helping millions live independently. A single injection improved brain function in early tests with no negative side effects.
Northwestern University researchers discovered a biomarker that could finally treat the cognitive symptoms of schizophrenia that current medications miss. A synthetic protein tested in animal models successfully reversed brain abnormalities linked to memory and thinking problems.
A groundbreaking study shows adding brexpiprazole to existing treatments helps people with schizophrenia think faster and process information better. The discovery opens new doors for treating one of the condition's most disabling symptoms that affects daily life and work.
A groundbreaking medication approved in 2024 treats schizophrenia through an entirely new approach, targeting brain receptors never before used in mental health treatment. The drug shows promise for managing symptoms without the severe metabolic side effects that have plagued patients for decades.
Three mothers whose sons developed schizophrenia are fighting to change a broken mental health system. Their advocacy is creating real solutions for families navigating one of healthcare's toughest challenges.
A single family just crossed $1 billion in donations to mental health research, with their latest $280 million gift funding breakthroughs in bipolar disorder and schizophrenia. The timing couldn't be better as federal research funding faces uncertainty.
After losing her mother and brother for 10 years to untreated schizophrenia, Neha Kirpal co-founded Amaha to transform mental healthcare access across India. Her childhood survival became millions of people's lifeline to support.
Showing 20 of 65